{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:42:49Z","timestamp":1792795369373,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12350-018-01484-z","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T12:10:48Z","timestamp":1543407048000},"page":"2018-2030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging"],"prefix":"10.1016","volume":"26","author":[{"given":"Jamshid","family":"Maddahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Dahlbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Schelbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Lazewatsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-01484-z_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.nuclcard.2007.07.009","article-title":"Mechanism of uptake and retention of 18F BMS747158-02 in cardiomyocytes: A novel PET myocardial imaging agent","volume":"14","author":"Yalamanchili","year":"2007","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0022-2828(92)93381-S","article-title":"Ultrastuctural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man","volume":"24","author":"Barth","year":"1992","journal-title":"J Mol Cell Cardiol"},{"key":"10.1007\/s12350-018-01484-z_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.nuclcard.2007.07.008","article-title":"BMS747158-02: A novel PET myocardial perfusion imaging agent","volume":"14","author":"Yu","year":"2007","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2967\/jnumed.107.044727","article-title":"Initial characterization of an 18F-labeled myocardial perfusion tracer","volume":"49","author":"Huisman","year":"2008","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-018-01484-z_bib5","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/CIRCULATIONAHA.108.797761","article-title":"Evaluation of the novel myocardial perfusion PET tracer 18F-BMS747158-02: Comparison to 13N ammonia and validation with microspheres in a pig model","volume":"119","author":"Nekolla","year":"2009","journal-title":"Circulation."},{"key":"10.1007\/s12350-018-01484-z_bib6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2967\/jnumed.111.092528","article-title":"Phase I, first-in-human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion PET imaging: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest","volume":"52","author":"Maddahi","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01484-z_bib7","unstructured":"International Commission on Radiological Protection (ICRP), Recommendations of the International Commission on Radiological Protection, Publication 60, Ann ICRP; 1990, 21, pp. 7-9."},{"key":"10.1007\/s12350-018-01484-z_bib8","first-page":"1023","article-title":"OLINDA\/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-018-01484-z_bib9","first-page":"37S","article-title":"MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-018-01484-z_bib10","unstructured":"International Commission on Radiological Protection (ICRP), Basic Anatomical & Physiological Data for use in Radiological Protection\u2014The Skeleton, Publication 70; 1995, Ann ICRP, 21, p. 66."},{"key":"10.1007\/s12350-018-01484-z_bib11","first-page":"613","article-title":"The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man","volume":"23","author":"Jones","year":"1982","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-018-01484-z_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12350-010-9246-y","article-title":"ASNC imaging guidelines for nuclear cardiology procedures\u2014single photon emission computed tomography","volume":"17","author":"Holly","year":"2010","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12350-009-9094-9","article-title":"ASNC Imaging Guidelines for Nuclear Cardiology Procedures\u2014PET myocardial perfusion and glucose metabolism clinical imaging","volume":"16","author":"Dilsizian","year":"2009","journal-title":"J Nucl Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2967\/jnumed.110.077669","article-title":"Human biodistribution and radiation dosimetry of 82Rb","volume":"51","author":"Senthamizhchelvan","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01484-z_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2967\/jnumed.110.083477","article-title":"Radiation dosimetry of 82Rb in humans under pharmacologic stress","volume":"52","author":"Senthamizhchelvan","year":"2011","journal-title":"J. Nucl Med"},{"key":"10.1007\/s12350-018-01484-z_bib16","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection (ICRP), Radiation Dose to Patients from Radiopharmaceutcals (Addendum to ICRP Publication 53), Publication 80, Ann ICRP; 1999, 28, p. 23.","DOI":"10.1016\/S0146-6453(99)00006-8"},{"key":"10.1007\/s12350-018-01484-z_bib17","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection (ICRP), Radiation Dose to Patients from Radiopharmaceuticals (Addendum to ICRP Publication 53), Publication 80, Ann ICRP, 1999, 28, pp. 109-10.","DOI":"10.1016\/S0146-6453(99)00006-8"},{"key":"10.1007\/s12350-018-01484-z_bib18","unstructured":"International Commission on Radiological Protection (ICRP), Radiation Dose to Patients from Radiopharmaceuticals, Publication 53, Ann ICRP, 1987, 18, pp. 61-2."},{"key":"10.1007\/s12350-018-01484-z_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00259-007-0554-7","article-title":"Iodine-124 PET dosimetry in differentiated thyroid cancer: Recovery coefficient in 2D and 3D modes for PET(\/CT) systems","volume":"35","author":"Jentzen","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-018-01484-z_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9149(78)90165-0","article-title":"Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation","volume":"41","author":"Gould","year":"1978","journal-title":"Am J Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/0002-8703(82)90564-6","article-title":"Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging","volume":"103","author":"Josephson","year":"1982","journal-title":"Am Heart J."},{"key":"10.1007\/s12350-018-01484-z_bib22","first-page":"1429","article-title":"New effective dose estimates for Rubidium-82 based on dynamic PET\/CT imaging in humans","volume":"51","author":"Hunter","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01484-z_bib23","first-page":"109","article-title":"Imaging properties of F-18 labeled myocardial perfusion PET agent, BMS747158: Dosage, acquisition time, and scanner type","volume":"50","author":"Case","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-018-01484-z_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2012.11.022","article-title":"Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F 18 positron emission tomography","volume":"61","author":"Berman","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-018-01484-z_bib25","first-page":"744","article-title":"The first phase 3 international multicenter clinical trial of Flurpiridaz F18, a new radiopharmaceutical for PET Myocardial perfusion imaging (abstract)","volume":"22","author":"Maddahi","year":"2015","journal-title":"J Nucl Cardiol."}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-018-01484-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123063754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123063754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-01484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:06:13Z","timestamp":1761026773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123063754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1071358123063754"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-01484-z","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-01484-z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}